1. Home
  2. PCRX vs ACIC Comparison

PCRX vs ACIC Comparison

Compare PCRX & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • ACIC
  • Stock Information
  • Founded
  • PCRX 2006
  • ACIC 1999
  • Country
  • PCRX United States
  • ACIC United States
  • Employees
  • PCRX N/A
  • ACIC N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • ACIC Property-Casualty Insurers
  • Sector
  • PCRX Health Care
  • ACIC Finance
  • Exchange
  • PCRX Nasdaq
  • ACIC Nasdaq
  • Market Cap
  • PCRX 604.7M
  • ACIC 632.9M
  • IPO Year
  • PCRX 2011
  • ACIC N/A
  • Fundamental
  • Price
  • PCRX $20.61
  • ACIC $11.85
  • Analyst Decision
  • PCRX Buy
  • ACIC Buy
  • Analyst Count
  • PCRX 10
  • ACIC 1
  • Target Price
  • PCRX $26.60
  • ACIC $16.00
  • AVG Volume (30 Days)
  • PCRX 754.5K
  • ACIC 182.8K
  • Earning Date
  • PCRX 02-27-2025
  • ACIC 02-27-2025
  • Dividend Yield
  • PCRX N/A
  • ACIC 4.22%
  • EPS Growth
  • PCRX N/A
  • ACIC N/A
  • EPS
  • PCRX N/A
  • ACIC 1.76
  • Revenue
  • PCRX $694,957,000.00
  • ACIC $290,784,000.00
  • Revenue This Year
  • PCRX $4.94
  • ACIC N/A
  • Revenue Next Year
  • PCRX N/A
  • ACIC $12.68
  • P/E Ratio
  • PCRX N/A
  • ACIC $6.75
  • Revenue Growth
  • PCRX 4.40
  • ACIC 1.02
  • 52 Week Low
  • PCRX $11.16
  • ACIC $8.82
  • 52 Week High
  • PCRX $34.01
  • ACIC $15.08
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 65.95
  • ACIC 34.10
  • Support Level
  • PCRX $18.18
  • ACIC $11.83
  • Resistance Level
  • PCRX $19.45
  • ACIC $12.44
  • Average True Range (ATR)
  • PCRX 0.77
  • ACIC 0.50
  • MACD
  • PCRX -0.04
  • ACIC -0.19
  • Stochastic Oscillator
  • PCRX 91.70
  • ACIC 4.59

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About ACIC American Coastal Insurance Corporation

American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary. The company has two segments namely: Commercial Lines Business and Personal Lines Business. It derives maximum revenue from Commercial Lines Business Segment.

Share on Social Networks: